In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...